Fate Therapeutics Inc (FATE) Insider Trading
- $140,338,122.89
- $85,937,046.68
- Aug. 6, 2024
- J Scott Wolchko
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 16, 2021 | VP | 3,275 | $83.30 | Sell | $272,807.50 | |
April 1, 2021 | Insider | 30,000 | $83.81 | Sell | $2,514,300.00 | |
March 15, 2021 | Insider | 25,000 | $92.35 | Sell | $2,308,750.00 | |
Jan. 21, 2021 | CEO | 30,000 | $103.05 | Sell | $3,091,500.00 | |
Jan. 19, 2021 | General Counsel | 35,000 | $114.76 | Sell | $4,016,600.00 | |
Jan. 11, 2021 | Insider | 9,482 | $114.95 | Sell | $1,089,955.90 | |
Jan. 11, 2021 | CEO | 69,407 | $116.33 | Sell | $8,074,116.31 | |
Jan. 11, 2021 | General Counsel | 9,483 | $114.94 | Sell | $1,089,976.02 | |
Jan. 8, 2021 | General Counsel | 6,229 | $117.10 | Sell | $729,415.90 | |
Jan. 8, 2021 | CEO | 60,820 | $117.10 | Sell | $7,122,022.00 | |
Jan. 8, 2021 | Director | 327,485 | $85.50 | Buy | $27,999,967.50 | |
Jan. 8, 2021 | Insider | 6,230 | $117.10 | Sell | $729,533.00 | |
Nov. 16, 2020 | Insider | 25,000 | $51.83 | Sell | $1,295,750.00 | |
Nov. 13, 2020 | CEO | 60,000 | $51.87 | Sell | $3,112,200.00 | |
Oct. 16, 2020 | General Counsel | 29,199 | $50.25 | Sell | $1,467,249.75 | |
June 11, 2020 | Director | 1,412,928 | $28.31 | Buy | $39,999,991.68 | |
Jan. 30, 2020 | CEO | 25,000 | $25.45 | Sell | $636,250.00 | |
Jan. 8, 2020 | Insider | 5,700 | $20.69 | Sell | $117,933.00 | |
Dec. 20, 2019 | CEO | 25,000 | $20.17 | Sell | $504,250.00 | |
Oct. 15, 2019 | General Counsel | 10,200 | $14.24 | Sell | $145,248.00 | |
Oct. 15, 2019 | Insider | 6,200 | $14.18 | Sell | $87,916.00 | |
Oct. 15, 2019 | CEO | 21,017 | $14.44 | Sell | $303,485.48 | |
Sept. 16, 2019 | Director | 857,143 | $17.50 | Buy | $15,000,002.50 | |
Aug. 1, 2019 | Director | 62,005 | $22.53 | Sell | $1,396,972.65 | |
July 30, 2019 | Director | 118,333 | $22.51 | Sell | $2,663,675.83 | |
July 26, 2019 | Director | 27,829 | $22.50 | Sell | $626,152.50 | |
July 24, 2019 | Director | 81,899 | $22.51 | Sell | $1,843,546.49 | |
July 22, 2019 | Director | 71,166 | $22.52 | Sell | $1,602,658.32 | |
July 18, 2019 | Director | 21,409 | $22.50 | Sell | $481,702.50 | |
June 27, 2019 | Insider | 12,500 | $20.21 | Sell | $252,625.00 | |
May 16, 2019 | Insider | 14,335 | $19.37 | Sell | $277,668.95 | |
April 17, 2019 | CEO | 8,541 | $16.17 | Sell | $138,107.97 | |
March 28, 2019 | Insider | 12,500 | $16.94 | Sell | $211,750.00 | |
March 21, 2019 | Insider | 20,000 | $17.61 | Sell | $352,200.00 | |
March 1, 2019 | General Counsel | 25,000 | $16.15 | Sell | $403,750.00 | |
Feb. 25, 2019 | General Counsel | 25,000 | $16.07 | Sell | $401,750.00 | |
Jan. 30, 2019 | Director | 53,017 | $14.16 | Sell | $750,720.72 | |
Jan. 28, 2019 | Director | 70,000 | $13.78 | Sell | $964,600.00 | |
Jan. 25, 2019 | Director | 90,000 | $14.14 | Sell | $1,272,600.00 | |
Jan. 18, 2019 | Director | 39,483 | $16.28 | Sell | $642,783.24 | |
Jan. 7, 2019 | General Counsel | 25,000 | $16.00 | Sell | $400,000.00 | |
Dec. 19, 2018 | Director | 91,210 | $13.40 | Sell | $1,222,214.00 | |
Dec. 13, 2018 | Director | 17,788 | $16.67 | Sell | $296,525.96 | |
Dec. 11, 2018 | Director | 82,528 | $16.71 | Sell | $1,379,042.88 | |
Sept. 25, 2018 | Director | 3,703,704 | $13.50 | Buy | $50,000,004.00 | |
Oct. 16, 2017 | General Counsel | 8,091 | $3.85 | Sell | $31,150.35 | |
Oct. 16, 2017 | Insider | 13,225 | $3.87 | Sell | $51,180.75 | |
Nov. 23, 2016 | Director | 375,939 | $2.66 | Buy | $999,997.74 | |
Nov. 23, 2016 | Insider | 37,593 | $2.66 | Buy | $99,997.38 | |
June 12, 2014 | Insider | 6,488 | $7.00 | Sell | $45,416.00 |
Insiders are both buying and selling Fate Therapeutics Inc stock.
The insider traders at Fate Therapeutics Inc are: J Scott Wolchko, Cindy Tahl, Amir Nashat, Bahram Valamehr, Edward J Dulac III, Redmile Group, Llc, Daniel D Shoemaker, Yu-Waye Chu, John Mendlein, Peter D Flynn, Yuan Xu, Chris Storgard, Brian T Powl, Shefali Agarwal, Valamehr Bahram, Venture Fund Vi Lp Arch, William H Rastetter, Mark Plavsic, and Christian Weyer
The most active insider trader at Fate Therapeutics Inc is J Scott Wolchko with 22 trades.
J Scott Wolchko has sold the most Fate Therapeutics Inc stock with a total value of $38,805,080.89.
Redmile Group, Llc has bought the most Fate Therapeutics Inc stock with a total value of $133,606,012.88.
The most recent insider trade for Fate Therapeutics Inc was on Aug. 6, 2024.
The single biggest insider buy for Fate Therapeutics Inc was from Redmile Group, Llc with a total value of $50,000,004.00 on Sept. 25, 2018.
The single biggest insider sell for Fate Therapeutics Inc was from J Scott Wolchko with a total value of $8,074,116.31 on Jan. 11, 2021.